Skip to main content

ESTRUCTURA DE PROTEINAS DE UNION A DNA, COMPLEJOS Y MAQUINAS MOLECULARES

BFU2014-53550-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Conformational plasticity of RepB, the replication initiator protein of promiscuous streptococcal plasmid pMV158

  • Boer, Roeland
  • Ruiz-Masó, José A.
  • Rueda, Manuel
  • Petoukhov, Maxim V.
  • Machón, Cristina
  • Svergun, Dmitri I.
  • Orozco, Modesto
  • Solar, Gloria del
  • Coll, Miquel
13 p.-7 fig.-1 tab., DNA replication initiation is a vital and tightly regulated step in all replicons and requires an initiator factor that specifically recognizes the DNA replication origin and starts replication. RepB from the promiscuous streptococcal plasmid pMV158 is a hexameric ring protein evolutionary related to viral initiators. Here we explore the conformational plasticity of the RepB hexamer by i) SAXS, ii)sedimentation experiments, iii) molecular simulations and iv) X-ray crystallography. Combining these techniques, we derive an estimate of the conformational ensemble in solution showing that the C-terminal oligomerisation domains of the protein form a rigid cylindrical scaffold to which the N-terminal DNA-binding/catalytic domains are attached as highly flexible appendages, featuring multiple orientations. In addition, we show that the hinge region connecting both domains plays a pivotal role in the observed plasticity. Sequence comparisons and a literature survey show that this hinge region could exists in other initiators, suggesting that it is a common, crucial structural element for DNA binding and manipulation., This study was supported by the Ministerio de Economía y Competitividad (Grants BFU2008-02372/BMC; BFU2011-22588, BFU2014-53550 and Unidad de Excelencia Maria de Maeztu MDM-2014-0435 to MC; BIO2009-10964 and E-SCIENCE to MO;BFU2010-19597, PNEUMOTALK, and CSD2008-00013, INTERMODS, to GdS; Ramón and Cajal subprogramme RYC-2011-09071 to CM), the Generalitat de Catalunya (Grants 2014-SGR1309 to MC and SGR2009-1348 to MO),Fundación Marcelino Botín (MO) and the European Commission (Cooperation Project SILVER, GA No. 260644 to MC and SCALALIFE Project to MO)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A C2HC zinc finger is essential for the RING-E2 interaction of the ubiquitin ligase RNF125

  • Bijlmakers, Marie-José
  • Teixeira, João M. C.
  • Boer, Roeland
  • Mayzel, Maxim
  • Puig-Sàrries, Pilar
  • Karlsson, Göran
  • Coll, Miquel
  • Pons, Mònica
  • Crosas, Bernat
The activity of RING ubiquitin ligases (E3s) depends on an interaction between the RING domain and ubiquitin conjugating enzymes (E2), but posttranslational events or additional structural elements, yet largely undefined, are frequently required to enhance or regulate activity. Here, we show for the ubiquitin ligase RNF125 that, in addition to the RING domain, a C2HC Zn finger (ZnF) is crucial for activity, and a short linker sequence (Li2120-128) enhances activity. The contribution of these regions was first shown with truncated proteins, and the essential role of the ZnF was confirmed with mutations at the Zn chelating Cys residues. Using NMR, we established that the C2HC ZnF/Li2120-128 region is crucial for binding of the RING domain to the E2 UbcH5a. The partial X-ray structure of RNF125 revealed the presence of extensive intramolecular interactions between the RING and C2HC ZnF. A mutation at one of the contact residues in the C2HC ZnF, a highly conserved M112, resulted in the loss of ubiquitin ligase activity. Thus, we identified the structural basis for an essential role of the C2HC ZnF and conclude that this domain stabilizes the RING domain, and is therefore required for binding of RNF125 to an E2., This work was supported by the Spanish Ministry of Economy, and Competitivity (MINECO) grant BIO2013-45993R and Almirall S.A to MB, PP and BC, and by MINECO grant BIO2013– 45793R, cofinanced with structural funds (FEDER) from the European Union, to JT and MP. MP, JT, MM and GK were also supported by the European Commission’s Framework Program 7 (BioNMR, contract 261863). RB and MC were supported by MINECO grants BFU2011-22588, BFU2014-53550-P, MDM-2014-0435., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structural basis of a histidine-DNA nicking/joining mechanism for gene transfer and promiscuous spread of antibiotic resistance

  • Pluta, Radoslaw
  • Roeland Boer, D.
  • Lorenzo-Díaz, Fabián
  • Russi, Silvia
  • Gómez, Hansel
  • Fernández-López, Cris
  • Pérez-Luque, Rosa
  • Orozco, Modesto
  • Espinosa, Manuel
  • Coll, Miquel
Relaxases are metal-dependent nucleases that break and join DNA for the initiation and completion of conjugative bacterial gene transfer. Conjugation is the main process through which antibiotic resistance spreads among bacteria, with multidrug-resistant staphylococci and streptococci infections posing major threats to human health. The MOBV family of relaxases accounts for approximately 85% of all relaxases found in Staphylococcus aureus isolates. Here, we present six structures of the MOBV relaxase MobM from the promiscuous plasmid pMV158 in complex with several origin of transfer DNA fragments. A combined structural, biochemical, and computational approach reveals that MobM follows a previously uncharacterized histidine/metal-dependent DNA processing mechanism, which involves the formation of a covalent phosphoramidate histidine-DNA adduct for cell-to-cell transfer. We discuss how the chemical features of the high-energy phosphorus-nitrogen bond shape the dominant position of MOBV histidine relaxases among small promiscuous plasmids and their preference toward Gram-positive bacteria., The Institute for Research in Biomedicine Barcelona is the recipient of a Severo Ochoa Award of Excellence from the Spanish Ministry of Economy and Competitiveness (MINECO). The Molecular Biology Institute, Barcelona Spanish Research Council’s Structural Biology Unit is the recipient of a Maria de Maeztu Award of Excellence from MINECO. This work was supported by grants from MINECO (BFU2008-02372/ BMC, CSD-2006-23, BFU2011-22588, CSD-2008/00013, BIO2013-49148-C2-2-R, BFU2014-53550-P, BIO2015-69085-REDC, and BIO2015-64802), the Generalitat de Catalunya (2014-SGR134 and 2014-SGR1530), and the European Commission [project no. 260644, ERC_SimDNA, and the H2020 program (MuG and BioExcel Projects)]. R.P. and H.G. received a La Caixa/Institute for Research in Biomedicine Barcelona International PhD and Juan de La Cierva fellowship, respectively. M.O. is a Catalan Institution for Research and Advanced Studies Academia researcher., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Intercalative DNA binding of the marine anticancer drug variolin B

  • Canals, Albert
  • Arribas-Bosacoma, Raquel
  • Albericio, Fernando
  • Álvarez, Mercedes
  • Aymamí, Joan
  • Coll, Miquel
Variolin B is a rare marine alkaloid that showed promising anti-cancer activity soon after its isolation. It acts as a cyclin-dependent kinase inhibitor, although the precise mechanism through which it exerts the cytotoxic effects is still unknown. The crystal structure of a variolin B bound to a DNA forming a pseudo-Holliday junction shows that this compound can also contribute, through intercalative binding, to either the formation or stabilization of multi-stranded DNA forms., This work was supported by the Spanish Ministry of Science and Innovation (grants BFU2008-02372/BMC, CONSOLIDER CSD 2006-23, BFU2011-22588, BFU2014-53550-P, CTQ2012-30930 and Unidad de Excelencia Maria de Maeztu MDM-2014-0435), the Generalitat de Catalunya (grants SGR2009-1309 and 2009SGR1024). Synchrotron data collection was supported by the ESRF and the EC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structure-driven discovery of α,γ-diketoacid inhibitors against UL89 herpesvirus terminase

  • Bongarzone, Salvatore
  • Nadal, Marta
  • Kaczmarska, Zuzanna
  • Machón, Cristina
  • Álvarez, Mercedes
  • Albericio, Fernando
  • Coll, Miquel
This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes., Human cytomegalovirus (HCMV) is an opportunistic pathogen causing a variety of severe viral infections, including irreversible congenital disabilities. Nowadays, HCMV infection is treated by inhibiting the viral DNA polymerase. However, DNA polymerase inhibitors have several drawbacks. An alternative strategy is to use compounds against the packaging machinery or terminase complex, which is essential for viral replication. Our discovery that raltegravir (1), a human immunodeficiency virus drug, inhibits the nuclease function of UL89, one of the protein subunits of the complex, prompted us to further develop terminase inhibitors. On the basis of the structure of 1, a library of diketoacid (α,γ-DKA and β,δ-DKA) derivatives were synthesized and tested for UL89-C nuclease activity. The mode of action of α,γ-DKA derivatives on the UL89 active site was elucidated by using X-ray crystallography, molecular docking, and in vitro experiments. Our studies identified α,γ-DKA derivative 14 able to inhibit UL89 in vitro in the low micromolar range, making 14 an optimal candidate for further development and virus-infected cell assay., S.B. was supported by COFUND/Marie Curie fellowship (European Commission FP7). CM was supported by the RYC fellowship (grant RYC2011-09071) from the Ministerio de Economia y Competividad (MINECO). The Institute for Research in Biomedicine Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO. The work was partially supported by grants from the MINECO (grants BFU2011-22588, CTQ2012-30930, CTQ2015-67870P, BFU2014-53550-P, BFU2017-83720-P, Marí a de Maeztu Award of Excellence MDM-2014-0435), the Generalitat de Catalunya (grants 2014 SGR 1530 and 2014 SGR 137) and the European Commission FP7 (Project SILVER-GA no. 260644)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Atomic structure of the Epstein-Barr virus portal

  • Machón, Cristina
  • Fàbrega-Ferrer, Montserrat
  • Zhou, Daming
  • Cuervo, Ana
  • Carrascosa, José L.
  • Stuart, David I.
  • Coll, Miquel
© The Author(s) 2019., Herpesviridae is a vast family of enveloped DNA viruses that includes eight distinct human pathogens, responsible for diseases that range from almost asymptomatic to severe and life-threatening. Epstein-Barr virus infects B-cells and epithelial cells, causing infectious mononucleosis, as well as a number of cancers. Epstein-Barr infection cannot be cured since neither vaccine nor antiviral drug treatments are available. All herpesviruses contain a linear double-stranded DNA genome, enclosed within an icosahedral capsid. Viral portal protein plays a key role in the procapsid assembly and DNA packaging. The portal is the entrance and exit pore for the viral genome, making it an attractive pharmacological target for the development of new antivirals. Here we present the atomic structure of the portal protein of Epstein-Barr virus, solved by cryo-electron microscopy at 3.5 Å resolution. The detailed architecture of this protein suggests that it plays a functional role in DNA retention during packaging., This work was partly supported by the Ministry of Science, Innovation and Universities of Spain, grants BFU2014-53550-P and BFU2017-83720-P (to M.C.), BFU 2014-54181 (to J.L.C.), and contracts SEV-2013-0347 (to A.C.), and RYC-2011-09071 (to C.M.). We acknowledge institutional funding through the Spanish Government Centres and Units of Excellence, Severo Ochoa and María de Maeztu awards, to IRB-Barcelona (SEV-2015-0500) and IBMB Structural Biology Unit (MDM-2014-0435), respectively; and from the CERCA Programme of the Catalan Government to IRB-Barcelona. This work has also been supported by iNEXT, grant number 653706, funded by the Horizon 2020 programme of the European Commission.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structures of T7 bacteriophage portal and tail suggest a viral DNA retention and ejection mechanism

  • Cuervo, Ana
  • Fàbrega-Ferrer, Montserrat
  • Machón, Cristina
  • Conesa, José J.
  • Fernández, Francisco J.
  • Pérez-Luque, Rosa
  • Pérez-Ruiz, Mar
  • Pous, Joan
  • Vega, María Cristina
  • Carrascosa, José L.
  • Coll, Miquel
Double-stranded DNA bacteriophages package their genome at high pressure inside a procapsid through the portal, an oligomeric ring protein located at a unique capsid vertex. Once the DNA has been packaged, the tail components assemble on the portal to render the mature infective virion. The tail tightly seals the ejection conduit until infection, when its interaction with the host membrane triggers the opening of the channel and the viral genome is delivered to the host cell. Using high-resolution cryo-electron microscopy and X-ray crystallography, here we describe various structures of the T7 bacteriophage portal and fiber-less tail complex, which suggest a possible mechanism for DNA retention and ejection: a portal closed conformation temporarily retains the genome before the tail is assembled, whereas an open portal is found in the tail. Moreover, a fold including a seven-bladed β-propeller domain is described for the nozzle tail protein., This work was supported by the Ministry of Science, Innovation and Universities of Spain, grants BFU 2014-54181 (to J.L.C.), BFU 2014-53550-P and BFU2017-83720-P (to M.C.), and contracts SEV-2013-0347 (to A.C.) and RYC-2011-09071 (to C.M.). We acknowledge institutional funding through the Spanish Government Centres and Units of Excellence Severo Ochoa and Maria de Maeztu awards to IRB Barcelona (SEV-2015-0500) and IBMB Structural Biology Unit (MDM-2014-0435), respectively, and from the CERCA Programme of the Catalan Government to the IRB Barcelona. This work has also been supported by the European Commission, Horizon 2020 program through iNEXT project (grant number 653706).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Using a partial atomic model from medium- resolution cryo-EM to solve a large crystal structure

  • Fàbrega-Ferrer, Montserrat
  • Cuervo, Ana
  • Fernández, Francisco J.
  • Machón, Cristina
  • Pérez-Luque, Rosa
  • Pous, Joan
  • Vega, María Cristina
  • Carrascosa, José L.
  • Coll, Miquel
Medium-resolution cryo-electron microscopy maps, in particular when they include a significant number of α-helices, may allow the building of partial models that are useful for molecular-replacement searches in large crystallo­graphic structures when the structures of homologs are not available and experimental phasing has failed. Here, as an example, the solution of the structure of a bacteriophage portal using a partial 30% model built into a 7.8 Å resolution cryo-EM map is shown. Inspection of the self-rotation function allowed the correct oligomerization state to be determined, and density-modification procedures using rotation matrices and a mask based on the cryo-EM structure were critical for solving the structure. A workflow is described that may be applicable to similar cases and this strategy is compared with direct use of the cryo-EM map for molecular replacement., The following funding is acknowledged: Ministry of Science, Innovation and Universities of Spain (grant Nos. BFU2014-53550-P and BFU2017-83720-P to Miquel Coll; grant No. BFU2014-54181 to Jose´ L. Carrascosa; contract No. SEV2013-0347 to Ana Cuervo; contract No. RYC-2011-09071 to Cristina Machon; award No. SEV-2015-0500 to IRB Barcelona; award No. MDM-2014-0435 to IBMB Structural Biology Unit); Catalan Government CERCA Programme (grant to IRB Barcelona).